Lv2
138 积分 2022-11-20 加入
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy
2天前
已完结
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water Molecule
4个月前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers
4个月前
已完结
Hepatic GPR75 exacerbates MASH through GNAI2-Dependent signaling
5个月前
已完结
A review of blood pressure measurement protocols among hypertension trials: implications for “evidencebased” clinical practice
5个月前
已完结
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
7个月前
已完结
Targeting GPR31 to treat MASH
9个月前
已关闭
Targeting the ER stress sensor IRE1 protects the liver from fibrosis through the downregulation of the proteostasis factor P4HB/PDIA1
10个月前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
10个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
10个月前
已完结
皖公网安备34019202002308
